Theoretical Evaluation of Novel Thermolysin Inhibitors from Bacillus thermoproteolyticus. Possible Antibacterial Agents
Related Experiment Video
Updated: Nov 21, 2025
A New Screening Method for the Directed Evolution of Thermostable Bacteriolytic Enzymes
Published on: November 7, 2012
Emilio Lamazares1, Desmond MacLeod-Carey2, Fernando P Miranda3
1Pathophysiology Department, Biotechnology and Biopharmaceutical Laboratory, School of Biological Sciences, Universidad de Concepción, Victor Lamas 1290, P.O. Box 160-C, Concepción 4079386, Chile.
Abstract:
The search for new antibacterial agents that could decrease bacterial resistance is a subject in continuous development. Gram-negative and Gram-positive bacteria possess a group of metalloproteins belonging to the MEROPS peptidase (M4) family, which is the main virulence factor of these bacteria. In this work, we used the previous results of a computational biochemistry protocol of a series of ligands designed in silico using thermolysin as a model for the search of antihypertensive agents. Here, thermolysin from Bacillus thermoproteolyticus, a metalloprotein of the M4 family, was used to determine the most promising candidate as an antibacterial agent. Our results from docking, molecular dynamics simulation, molecular mechanics Poisson-Boltzmann (MM-PBSA) method, ligand efficiency, and ADME-Tox properties (Absorption, Distribution, Metabolism, Excretion, and Toxicity) indicate that the designed ligands were adequately oriented in the thermolysin active site. The Lig783, Lig2177, and Lig3444 compounds showed the best dynamic behavior; however, from the ADME-Tox calculated properties, Lig783 was selected as the unique antibacterial agent candidate amongst the designed ligands.
Insights
Researchers identified a novel antibacterial agent, Lig783, by computationally screening metalloproteinase inhibitors. This compound shows promise in combating bacterial resistance by targeting key virulence factors in Gram-negative and Gram-positive bacteria.
Area of Science:
- Biochemistry
- Computational Chemistry
- Pharmacology
Background:
- Bacterial resistance to antibiotics is a growing global health threat.
- Metalloproteinases from the MEROPS peptidase (M4) family are crucial virulence factors in Gram-negative and Gram-positive bacteria.
- Developing new antibacterial agents targeting these metalloproteinases is essential.
Purpose of the Study:
- To identify novel antibacterial agents by computationally screening ligands against thermolysin, a model metalloproteinase.
- To evaluate the potential of designed ligands as inhibitors of bacterial metalloproteinases.
- To select the most promising candidate based on molecular interactions and pharmacokinetic properties.
Main Methods:
- In silico ligand design and docking simulations using thermolysin as a model.
- Molecular dynamics (MD) simulations to assess ligand stability and dynamic behavior.
- Molecular Mechanics with the Poisson-Boltzmann Surface Area (MM-PBSA) method for binding free energy estimation.
- Ligand efficiency calculations and ADME-Tox (Absorption, Distribution, Metabolism, Excretion, and Toxicity) property predictions.
Main Results:
- Designed ligands demonstrated favorable interactions and orientation within the thermolysin active site.
- Lig783, Lig2177, and Lig3444 exhibited the most promising dynamic behavior during simulations.
- Lig783 was identified as the lead candidate due to its optimal ADME-Tox profile among the evaluated compounds.
Conclusions:
- Computational screening successfully identified potential antibacterial agents targeting bacterial metalloproteinases.
- Lig783 represents a promising candidate for further development as a novel antibacterial agent.
- The study highlights the utility of integrated computational approaches in drug discovery for combating antibiotic resistance.
More Related Videos
Related Concept Videos
01:28Biological Methods for Microbial Control
01:28Antimicrobial Effectiveness